Stock UNCY UNICYCIVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Unicycive Therapeutics, Inc.

Equities

UNCY

US90466Y1038

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.03 USD +6.19% Intraday chart for Unicycive Therapeutics, Inc. -3.74% +18.70%
Apr. 04 Piper Sandler Initiates Coverage on Unicycive Therapeutics With Overweight Rating, $9 Price Target MT
Mar. 28 Unicycive Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Unicycive Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

da9294188.CO4HfLT-eNE2Lc-SlxCwhP2gsIIoXoNpOvlLRu51sUM.JZZqPt6oK7x0a6v4pl_W4qvk2u5KBvI_VLgSLoBF-SdipmJM7rEpk2Nsmg~e0c896c2a944daa0d4e698dfac1118c0

Analyst Recommendations on Unicycive Therapeutics, Inc.

Piper Sandler Initiates Coverage on Unicycive Therapeutics With Overweight Rating, $9 Price Target MT
HC Wainwright Adjusts Unicycive Therapeutics' Price Target to $4.50 From $7, Keeps Buy Rating MT
Maxim Adjusts Price Target on Unicycive Therapeutics to $4 From $6, Maintains Buy Rating MT
Roth MKM Adjusts Price Target on Unicycive Therapeutics to $4 From $5, Maintains Buy Rating MT
EF Hutton Starts Unicycive Therapeutics at Buy With $5 Price Target MT
Maxim Adjusts Price Target on Unicycive Therapeutics to $6 From $3, Maintains Buy Rating MT
HC Wainwright Cuts Price Target on Unicycive Therapeutics to $8 From $9, Keeps Buy Rating MT
HC Wainwright Starts Unicycive Therapeutics at Buy With $9 Price Target MT
Maxim Initiates Unicycive Therapeutics at Buy with $3 Price Target MT
UNICYCIVE THERAPEUTICS : Benchmark Starts Unicycive Therapeutics at Speculative Buy With $13 Price Target MT
UNICYCIVE THERAPEUTICS : Roth Capital Starts Unicycive Therapeutics at Buy With $13.50 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.03 USD
Average target price
5.3 USD
Spread / Average Target
+414.56%
High Price Target
9 USD
Spread / Highest target
+773.79%
Low Price Target
3 USD
Spread / Lowest Target
+191.26%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Unicycive Therapeutics, Inc.

Piper Sandler
HC Wainwright
Roth MKM
Maxim
EF Hutton
Benchmark Capital
Roth Capital Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. UNCY Stock
  4. Consensus Unicycive Therapeutics, Inc.